MediaMedic

Professor Francesca Lorraine Wei Inng Lim: The Cell Therapy Landscape in Singapore

By Peng Longmei 2025.09.17

On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology & Rare Disease…

Professor Ceshi Chen’s Speech at COMB 2025

By Mourabit Halima 2025.09.17

$Professor Junfang Yang: Clinical Research and Practice of CD7 CAR-T Therapy in Relapsed/Refractory Hematologic Malignancies$

Professor Junfang Yang: Clinical Research and Practice of CD7 CAR-T Therapy in Relapsed/Refractory Hematologic Malignancies

By Mourabit Halima 2025.09.17

On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, co-hosted by the Beijing Health Promotion Association and the Guangzhou Hongmian Oncology & Rare Disease Public…

Professor Jiong Wu’s Speech at COMB 2025

By Lisa Cui 2025.09.17

Professor Peng Yuan’s Speech at COMB 2025

By Peter W. PENG 2025.09.17

Professor Tao Sun’s Speech at COMB 2025

By Mourabit Halima 2025.09.17

2025 COMB丨Professor Peng Yuan: Multi-Gene Testing Drives Personalized Treatment and Illuminates a New Era in Precision Breast Cancer Care

By Mourabit Halima 2025.09.14

Editor’s Note: The 8th Conference on Oncology Precision Medicine and the 11th Conference on Individualized Therapy for Breast Cancer were recently held in Beijing, jointly organized by the Beijing Breast…

Professor Ping Zhang at COMB 2025: Breaking Through Endocrine Resistance—New Precision Pathways for HR+/HER2- Breast Cancer

By Mourabit Halima 2025.09.14

Editor’s Note: Endocrine resistance is one of the major challenges in the treatment of HR+/HER2- breast cancer. At the 8th Conference on Oncology Precision Medicine and the 11th Conference on…

Academician Xishan Hao: The Mission of Advancing Chinese Oncology and Building Academic Journal

By Peter W. PENG 2025.09.14

Editor’s Note: With China’s rapidly aging population, cancer prevention and treatment face new challenges and opportunities. As the birthplace of modern oncology in China, Tianjin Medical University Cancer Institute and…

Professor Xiaowei Qi: Preferred Neoadjuvant Strategies in HER2-Positive Breast Cancer and Breakthrough Directions in TNBC Immunotherapy

By Mourabit Halima 2025.09.14

Editor’s Note: The 2025 Summer Breast Cancer Forum · Northern Salon was held in Qingdao, Shandong, from August 8–10. Upholding the spirit of “learning and innovation” and the tradition of…

EBMT President Professor Ibrahim Yakoub-Agha: A Global Vision for the Future of Therapy—Strengthening Collaboration, Empowering Data, and Standardizing Cellular Therapies

EBMT Global Perspective | Professor Francesca Ferrua: Breakthroughs in Autologous Hematopoietic Stem Cell Gene Therapy for WAS—From Concept to Clinical Practice

EBMT Global Perspective | Professor Annalisa Ruggeri: Cord Blood Transplantation—From Established Platform to Frontier Therapeutic Modality

Professor Yuankai Shi: Thirty-Five Years of Iterative Innovation—Lymphoma Leading China’s Modernization in Oncology Drug Therapy | 2026 CACA Western Integrative Oncology Conference

Annual Meeting of the Hematology Branch, CPAM | Professor Yajing Xu: Long-Term Follow-Up Management After Hematopoietic Stem Cell Transplantation—From Digital Solutions to Primary Care Collaboration

AACR China Voice | Qilu Pharmaceutical Showcases Multiple Innovative Breakthroughs at AACR, Driving Global Advances in Oncology Through Originative Innovation

AACR China Voice | Professor Tao Zhu: First-in-Human Study of CLDN6 ADC QLS5132 Demonstrates Promising Efficacy and Safety, Opening New Directions for Platinum-Resistant Ovarian Cancer

EBMT 2026 Expert Interview: Prof. Annalisa Ruggeri on Cord Blood Transplantation

Advancing Hematology Care: Insights from Prof. Donal McLornan at EBMT 2026

EBMT 2026 Expert Interview: Prof. Francesca Ferrua on Advances in Hematology

EBMT President Professor Ibrahim Yakoub-Agha: A Global Vision for the Future of Therapy—Strengthening Collaboration, Empowering Data, and Standardizing Cellular Therapies

EBMT Global Perspective | Professor Francesca Ferrua: Breakthroughs in Autologous Hematopoietic Stem Cell Gene Therapy for WAS—From Concept to Clinical Practice

Professor Francesca Lorraine Wei Inng Lim: The Cell Therapy Landscape in Singapore

Professor Ceshi Chen’s Speech at COMB 2025

Professor Junfang Yang: Clinical Research and Practice of CD7 CAR-T Therapy in Relapsed/Refractory Hematologic Malignancies

Professor Jiong Wu’s Speech at COMB 2025

Professor Peng Yuan’s Speech at COMB 2025

Professor Tao Sun’s Speech at COMB 2025

2025 COMB丨Professor Peng Yuan: Multi-Gene Testing Drives Personalized Treatment and Illuminates a New Era in Precision Breast Cancer Care

Professor Ping Zhang at COMB 2025: Breaking Through Endocrine Resistance—New Precision Pathways for HR+/HER2- Breast Cancer

Academician Xishan Hao: The Mission of Advancing Chinese Oncology and Building Academic Journal

Professor Xiaowei Qi: Preferred Neoadjuvant Strategies in HER2-Positive Breast Cancer and Breakthrough Directions in TNBC Immunotherapy

EBMT President Professor Ibrahim Yakoub-Agha: A Global Vision for the Future of Therapy—Strengthening Collaboration, Empowering Data, and Standardizing Cellular Therapies

EBMT Global Perspective | Professor Francesca Ferrua: Breakthroughs in Autologous Hematopoietic Stem Cell Gene Therapy for WAS—From Concept to Clinical Practice

EBMT Global Perspective | Professor Annalisa Ruggeri: Cord Blood Transplantation—From Established Platform to Frontier Therapeutic Modality

Professor Yuankai Shi: Thirty-Five Years of Iterative Innovation—Lymphoma Leading China’s Modernization in Oncology Drug Therapy | 2026 CACA Western Integrative Oncology Conference

Welcome to Mediamedic 👋
It’s nice to meet you.

Welcome to Mediamedic 👋It’s nice to meet you.

Welcome to Mediamedic 👋
It’s nice to meet you.